MX356853B - Sintesis de una saponina esteroidea. - Google Patents

Sintesis de una saponina esteroidea.

Info

Publication number
MX356853B
MX356853B MX2014014056A MX2014014056A MX356853B MX 356853 B MX356853 B MX 356853B MX 2014014056 A MX2014014056 A MX 2014014056A MX 2014014056 A MX2014014056 A MX 2014014056A MX 356853 B MX356853 B MX 356853B
Authority
MX
Mexico
Prior art keywords
provides
present
improved synthesis
class
steroid
Prior art date
Application number
MX2014014056A
Other languages
English (en)
Other versions
MX2014014056A (es
Inventor
Clive Muscroft-Taylor Andrew
andrew marshall Philip
Mary Mason Jennifer
Millar Walker David
Original Assignee
Oncology Res International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2012902119A external-priority patent/AU2012902119A0/en
Application filed by Oncology Res International Limited filed Critical Oncology Res International Limited
Publication of MX2014014056A publication Critical patent/MX2014014056A/es
Publication of MX356853B publication Critical patent/MX356853B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J17/005—Glycosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención proporciona una síntesis mejorada de una clase saponinas esteroideas. Además, la presente invención proporciona un método para discriminar selectivamente entre los grupos hidroxilo de C2 y C3 de una saponina esteroidea monoglicosilada -un paso clave en la reparación de ésta clase de compuestos. Adicionalmente, la presente invención proporciona una gama de derivados de saponina esteroidea, y métodos para prepararlos.
MX2014014056A 2012-05-23 2013-04-24 Sintesis de una saponina esteroidea. MX356853B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2012902119A AU2012902119A0 (en) 2012-05-23 Improved synthesis
AU2013204005A AU2013204005B2 (en) 2012-05-23 2013-04-11 Improved synthesis
PCT/AU2013/000416 WO2013173862A1 (en) 2012-05-23 2013-04-24 Improved synthesis

Publications (2)

Publication Number Publication Date
MX2014014056A MX2014014056A (es) 2015-08-14
MX356853B true MX356853B (es) 2018-06-18

Family

ID=49622929

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014014056A MX356853B (es) 2012-05-23 2013-04-24 Sintesis de una saponina esteroidea.

Country Status (13)

Country Link
US (1) US20150105543A1 (es)
EP (1) EP2852607B1 (es)
JP (1) JP2015517535A (es)
CN (1) CN104395333B (es)
AU (1) AU2013204005B2 (es)
BR (1) BR112014029189A2 (es)
CA (1) CA2874030A1 (es)
EA (1) EA201492194A1 (es)
HK (1) HK1202876A1 (es)
IN (1) IN2014DN10846A (es)
MX (1) MX356853B (es)
TW (1) TWI609025B (es)
WO (1) WO2013173862A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103193858B (zh) * 2013-04-12 2016-08-03 中国海洋大学 螺甾碱烷型糖苷生物碱的合成方法
EP3580225A4 (en) * 2017-02-10 2021-01-06 Oncology Research International Limited STEROIDSAPONINS WITH ANTI-CANCER EFFECT
CN110790811A (zh) * 2019-10-10 2020-02-14 华南农业大学 双相体系氯化铝水解制备薯蓣皂素方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1115346C (zh) * 2000-10-20 2003-07-23 中国科学院上海有机化学研究所 鼠李糖取代的β－D－葡萄糖基－薯蓣皂甙的皂甙库、制备方法和用途
CN101130568B (zh) * 2007-09-07 2011-06-15 中国科学院上海有机化学研究所 一类喷脑皂甙类化合物、合成方法及其用途
KR101825315B1 (ko) * 2008-04-08 2018-02-02 슬로안-케테링인스티튜트퍼캔서리서치 트리테르펜 사포닌, 그의 합성 방법, 및 그의 용도
CN101635335B (zh) * 2008-07-25 2013-02-27 深圳市比克电池有限公司 圆柱电池卷芯入壳机

Also Published As

Publication number Publication date
CA2874030A1 (en) 2013-11-28
AU2013204005A1 (en) 2013-12-12
MX2014014056A (es) 2015-08-14
EP2852607A1 (en) 2015-04-01
EP2852607B1 (en) 2018-10-24
BR112014029189A2 (pt) 2017-06-27
JP2015517535A (ja) 2015-06-22
CN104395333B (zh) 2018-01-02
IN2014DN10846A (es) 2015-09-04
CN104395333A (zh) 2015-03-04
TW201350497A (zh) 2013-12-16
AU2013204005B2 (en) 2015-04-16
HK1202876A1 (en) 2015-10-09
US20150105543A1 (en) 2015-04-16
WO2013173862A1 (en) 2013-11-28
EP2852607A4 (en) 2016-02-24
TWI609025B (zh) 2017-12-21
EA201492194A1 (ru) 2015-04-30

Similar Documents

Publication Publication Date Title
NZ712350A (en) Abiraterone acetate formulation
MX2019008212A (es) Estructuras fibrosas que comprenden particulas y metodos para fabricarlas.
MX2015012401A (es) Composiciones y metodos de alterar niveles de colesterol.
WO2012174439A3 (en) Methods of producing1, 3 - butadiene
WO2013177419A3 (en) Lipid nanoparticle compositions and methods of making and methods of using the same
EP3468385A4 (en) STEVIOL GLYCOSIDE COMPOSITIONS, PRODUCTION METHODS AND USES
EP3192527A4 (en) Cancer-cell-specific antibody, anticancer agent, and cancer testing method
WO2012177935A8 (en) Compositions and methods for the treatment of cancer
AU2013225816A8 (en) Compositions and methods for treating Type III Gaucher Disease
MX2017013013A (es) Estireno funcionalizado con [bis(trihidrocarbilsilil)aminosililo] y un metodo para su preparacion.
EP3277820A4 (en) Methods for producing modified red blood cell compositions, compositions and uses thereof
MX356801B (es) Incremento en la biodisponibilidad de fármacos en la terapia con naltrexona.
WO2012075117A3 (en) Small molecule-polymer conjugates and methods of making same
WO2013040251A8 (en) Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
WO2013163297A8 (en) Modified glycoproteins
UY35986A (es) Método mejorado para la producción de extractos de ginkgo
WO2013052108A3 (en) Methods and compositions for the treatment and diagnosis of ovarian cancer
EP3698144A4 (en) COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER
MX356853B (es) Sintesis de una saponina esteroidea.
WO2011100642A3 (en) Method for treating hematological cancers
EP3357943A4 (en) Modifier and modified conjugated diene based polymer, and preparation methods therefor
EP3434765A4 (en) ANTI-TMEM-180 ANTIBODIES, ANTI-STEM AND TREATMENT FOR CANCER
PH12017500013A1 (en) Compositions and methods for enhancing immunity
EP3150638A4 (en) Conjugated diene polymer, method for producing same, and composition including same
MX2015016603A (es) Composiciones de corticosteroides.

Legal Events

Date Code Title Description
FG Grant or registration